Brown & Brown, Inc. announces quarterly revenues of $904.7 million, an increase of 11.0%, diluted net income per share of $0.77, Diluted Net Income Per Share – Adjusted of $0.78 and a quarterly dividend of $0.1025 per share
Revenues for the first quarter of 2022 under
In addition, the Company today announced that the Board of Directors has declared a regular quarterly cash dividend of
Reconciliation of Commissions and Fees | ||||||||
to Organic Revenue | ||||||||
Three Months Ended |
||||||||
(in millions, unaudited) | ||||||||
Three Months Ended | ||||||||
Commissions and fees | $ | 904.3 | $ | 814.0 | ||||
Profit-sharing contingent commissions | (28.6 | ) | (25.9 | ) | ||||
Core commissions and fees | 875.7 | 788.1 | ||||||
Acquisitions | (29.3 | ) | — | |||||
Dispositions | — | (2.4 | ) | |||||
Foreign Currency Translation | — | (0.7 | ) | |||||
Organic Revenue | $ | 846.4 | $ | 785.0 | ||||
Organic Revenue growth | $ | 61.4 | ||||||
Organic Revenue growth % | 7.8 | % |
See information regarding non-GAAP measures presented later in this press release.
Reconciliation of Diluted Net Income Per Share to | |||||||||||||||
Diluted Net Income Per Share - Adjusted | |||||||||||||||
Three Months Ended |
|||||||||||||||
(unaudited) | |||||||||||||||
Three Months Ended | Change | ||||||||||||||
$ | % | ||||||||||||||
Diluted net income per share | $ | 0.77 | $ | 0.70 | $ | 0.07 | 10.0 | % | |||||||
Change in estimated acquisition earn-out payables | (0.01 | ) | — | (0.01 | ) | ||||||||||
(Gain)/loss on disposal | — | — | — | ||||||||||||
Acquisition/Integration Costs | 0.02 | — | 0.02 | ||||||||||||
Foreign Currency Translation | — | — | — | ||||||||||||
Diluted Net Income Per Share - Adjusted | 0.78 | 0.70 | 0.08 | 11.4 | % |
See information regarding non-GAAP measures presented later in this press release.
Reconciliation of Total Revenues to Total Revenues - Adjusted, Income Before Income Taxes to EBITDAC - Adjusted and Income Before Income Taxes Margin to EBITDAC Margin - Adjusted Three Months Ended |
||||||||
(in millions, unaudited) | ||||||||
Three Months Ended | ||||||||
Total revenues | $ | 904.7 | $ | 815.3 | ||||
Foreign Currency Translation | (0.7 | ) | ||||||
Total Revenues - Adjusted | $ | 904.7 | $ | 814.6 | ||||
Income before income taxes | $ | 265.0 | $ | 239.2 | ||||
Income Before Income Taxes Margin | 29.3 | % | 29.3 | % | ||||
Amortization | 31.1 | 29.5 | ||||||
Depreciation | 8.1 | 7.5 | ||||||
Interest | 18.3 | 16.3 | ||||||
Change in estimated acquisition earn-out payables | (3.4 | ) | (0.9 | ) | ||||
EBITDAC | $ | 319.1 | $ | 291.6 | ||||
EBITDAC Margin | 35.3 | % | 35.8 | % | ||||
(Gain)/loss on disposal | (0.2 | ) | (0.2 | ) | ||||
Acquisition/Integration Costs | 4.4 | — | ||||||
Foreign Currency Translation | — | (0.3 | ) | |||||
EBITDAC - Adjusted | 323.3 | 291.1 | ||||||
EBITDAC Margin - Adjusted | 35.7 | % | 35.7 | % |
See information regarding non-GAAP measures presented later in this press release.
Consolidated Statements of Income | ||||||||
(in millions, except per share data; unaudited) | ||||||||
Three Months Ended |
||||||||
2022 | 2021 | |||||||
REVENUES | ||||||||
Commissions and fees | $ | 904.3 | $ | 814.0 | ||||
Investment income | 0.2 | 0.3 | ||||||
Other | 0.2 | 1.0 | ||||||
Total revenues | 904.7 | 815.3 | ||||||
EXPENSES | ||||||||
Employee compensation and benefits | 459.0 | 429.5 | ||||||
Other operating expenses | 126.8 | 94.4 | ||||||
(Gain)/loss on disposal | (0.2 | ) | (0.2 | ) | ||||
Amortization | 31.1 | 29.5 | ||||||
Depreciation | 8.1 | 7.5 | ||||||
Interest | 18.3 | 16.3 | ||||||
Change in estimated acquisition earn-out payables | (3.4 | ) | (0.9 | ) | ||||
Total expenses | 639.7 | 576.1 | ||||||
Income before income taxes | 265.0 | 239.2 | ||||||
Income taxes | 44.7 | 39.5 | ||||||
Net income | $ | 220.3 | $ | 199.7 | ||||
Net income per share: | ||||||||
Basic | $ | 0.78 | $ | 0.71 | ||||
Diluted | $ | 0.77 | $ | 0.70 | ||||
Weighted average number of shares outstanding - in thousands: | ||||||||
Basic | 277,059 | 275,594 | ||||||
Diluted | 278,566 | 276,955 | ||||||
Dividends declared per share | $ | 0.103 | $ | 0.093 |
Consolidated Balance Sheets | ||||||||
(in millions, except per share data, unaudited) | ||||||||
2022 |
2021 |
|||||||
ASSETS | ||||||||
Current assets: | ||||||||
Cash and cash equivalents | $ | 1,694.5 | $ | 693.2 | ||||
Fiduciary cash | 731.6 | 777.0 | ||||||
Short-term investments | 17.6 | 12.9 | ||||||
Commission, fees, and other receivable | 613.5 | 522.6 | ||||||
Fiduciary receivables | 706.1 | 693.7 | ||||||
Reinsurance recoverable | 38.4 | 63.1 | ||||||
Prepaid reinsurance premiums | 362.4 | 392.2 | ||||||
Other current assets | 144.8 | 175.6 | ||||||
Total current assets | 4,308.9 | 3,330.3 | ||||||
Fixed assets, net | 214.5 | 212.0 | ||||||
Operating lease assets | 204.2 | 197.0 | ||||||
5,140.9 | 4,736.8 | |||||||
Amortizable intangible assets, net | 1,171.0 | 1,081.5 | ||||||
Investments | 25.0 | 31.0 | ||||||
Other assets | 208.4 | 206.8 | ||||||
Total assets | $ | 11,272.9 | $ | 9,795.4 | ||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
Current liabilities: | ||||||||
Fiduciary liabilities | $ | 1,437.7 | $ | 1,470.7 | ||||
Losses and loss adjustment reserve | 38.4 | 63.1 | ||||||
Unearned premiums | 362.5 | 392.2 | ||||||
Accounts payable | 230.8 | 242.7 | ||||||
Accrued expenses and other liabilities | 327.0 | 456.2 | ||||||
Current portion of long-term debt | 42.5 | 42.5 | ||||||
Total current liabilities | 2,438.9 | 2,667.4 | ||||||
Long-term debt | 3,497.1 | 1,980.4 | ||||||
Operating lease liabilities | 185.7 | 180.0 | ||||||
Deferred income taxes, net | 432.0 | 386.8 | ||||||
Other liabilities | 383.9 | 383.9 | ||||||
Shareholders’ equity: | ||||||||
Common stock, par value |
30.2 | 30.1 | ||||||
Additional paid-in capital | 823.5 | 849.4 | ||||||
(698.0 | ) | (673.9 | ) | |||||
Accumulated other comprehensive loss | (12.4 | ) | (9.4 | ) | ||||
Retained earnings | 4,192.0 | 4,000.7 | ||||||
Total shareholders’ equity | 4,335.3 | 4,196.9 | ||||||
Total liabilities and shareholders’ equity | $ | 11,272.9 | $ | 9,795.4 |
Consolidated Statements of Cash Flows | ||||||||
(in millions, unaudited) | ||||||||
Three Months Ended |
||||||||
2022 | 2021 | |||||||
Cash flows from operating activities: | ||||||||
Net income | $ | 220.3 | $ | 199.7 | ||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Amortization | 31.1 | 29.5 | ||||||
Depreciation | 8.1 | 7.5 | ||||||
Non-cash stock-based compensation | 20.1 | 18.7 | ||||||
Change in estimated acquisition earn-out payables | (3.4 | ) | (0.9 | ) | ||||
Deferred income taxes | 15.2 | 10.6 | ||||||
Amortization of debt discount and disposal of deferred financing costs | 0.7 | 0.7 | ||||||
Net (gain)/loss on sales/disposals of investments, fixed assets and customer accounts | (0.1 | ) | (0.4 | ) | ||||
Payments on acquisition earn-outs in excess of original estimated payables | (13.5 | ) | (0.4 | ) | ||||
Effect of changes in foreign exchange rate | (0.1 | ) | 0.2 | |||||
Changes in operating assets and liabilities, net of effect from acquisitions and divestitures: | ||||||||
Commissions and fees receivable (increase)/decrease | (87.8 | ) | (88.6 | ) | ||||
Reinsurance recoverables (increase)/decrease | 24.8 | 17.2 | ||||||
Prepaid reinsurance premiums (increase)/decrease | 29.8 | 32.6 | ||||||
Other assets (increase)/decrease | 31.0 | 25.3 | ||||||
Losses and loss adjustment reserve increase/(decrease) | (24.8 | ) | (17.2 | ) | ||||
Unearned premiums increase/(decrease) | (29.7 | ) | (32.6 | ) | ||||
Accounts payable increase/(decrease) | 22.2 | 70.4 | ||||||
Accrued expenses and other liabilities increase/(decrease) | (143.1 | ) | (107.0 | ) | ||||
Other liabilities increase/(decrease) | 2.8 | (27.3 | ) | |||||
Net cash provided by operating activities | 103.6 | 138.0 | ||||||
Cash flows from investing activities: | ||||||||
Additions to fixed assets | (10.0 | ) | (11.4 | ) | ||||
Payments for businesses acquired, net of cash acquired | (436.0 | ) | (70.4 | ) | ||||
Proceeds from sales of fixed assets and customer accounts | 0.2 | 0.2 | ||||||
Purchases of investments | — | (5.1 | ) | |||||
Proceeds from sales of investments | — | 4.3 | ||||||
Net cash used in investing activities | (445.8 | ) | (82.4 | ) | ||||
Cash flows from financing activities: | ||||||||
Fiduciary receivables and liabilities, net | (85.2 | ) | (12.9 | ) | ||||
Payments on acquisition earn-outs | (33.4 | ) | (15.1 | ) | ||||
Proceeds from long-term debt | 1,200.0 | — | ||||||
Payments on long-term debt | (10.6 | ) | (17.5 | ) | ||||
Deferred debt issuance costs | (23.4 | ) | — | |||||
Borrowings on revolving credit facilities | 350.0 | — | ||||||
Repurchase shares to fund tax withholdings for non-cash stock-based compensation | (46.0 | ) | (45.1 | ) | ||||
Purchase of treasury stock | (24.1 | ) | (70.0 | ) | ||||
Cash dividends paid | (28.9 | ) | (26.1 | ) | ||||
Net cash (used in)/provided by financing activities | 1,298.4 | (186.7 | ) | |||||
Effect of foreign exchange rate changes in cash and cash equivalents inclusive of fiduciary cash | (0.4 | ) | (0.1 | ) | ||||
Net increase in cash and cash equivalents inclusive of fiduciary cash | 955.8 | (131.2 | ) | |||||
Cash and cash equivalents inclusive of fiduciary cash at beginning of period | 1,470.3 | 1,271.9 | ||||||
Cash and cash equivalents inclusive of fiduciary cash at end of period | $ | 2,426.1 | $ | 1,140.7 |
Conference call, webcast and slide presentation
A conference call to discuss the results of the first quarter of 2022 will be held on
About Brown & Brown
Forward-looking statements
This press release may contain certain statements relating to future results which are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. These forward-looking statements include information about possible or assumed future results of our operations. All statements, other than statements of historical facts, included in this press release that address activities, events or developments that we expect or anticipate may occur in the future, including those relating to the Company's anticipated financial results for the first quarter of 2022 and the potential effects of the COVID-19 pandemic (“COVID-19”) on the Company’s business, operations, financial performance and prospects, are forward-looking statements. These statements are not historical facts, but instead represent only the Company's current belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results, financial condition and achievements may differ, possibly materially, from the anticipated results, financial condition and achievements contemplated by these forward-looking statements. Also, when we use words such as ‘may’, ‘will’, ‘should’, ‘continue’, 'anticipate', 'believe', 'estimate', 'expect', 'intend', 'plan', 'probably' or similar expressions, we are making forward-looking statements. These risks and uncertainties include, but are not limited to, COVID-19 and the resulting governmental and societal responses, the severity and duration of COVID-19 (including through any new variant strains of the underlying virus), the effectiveness of and accessibility to vaccines, the pace and rate at which vaccines are administered, actions taken by governmental authorities in response to COVID-19 and the direct and indirect impact of COVID-19 on the
Non-GAAP supplemental financial information
This press release contains references to "non-GAAP financial measures" as defined in SEC Regulation G, consisting of Total Revenues - Adjusted, Organic Revenue, EBITDAC, EBITDAC Margin, EBITDAC - Adjusted, EBITDAC Margin - Adjusted and Diluted Net Income Per Share - Adjusted. We present these measures because we believe such information is of interest to the investment community and because we believe it provides additional meaningful methods to evaluate the Company’s operating performance from period to period on a basis that may not be otherwise apparent on a GAAP basis due to the impact of certain items that have a high degree of variability and that we believe are not indicative of ongoing performance. This non-GAAP financial information should be considered in addition to, not in lieu of, the Company’s consolidated income statements and balance sheets as of the relevant date. Consistent with Regulation G, a description of such information is provided below and a reconciliation of such items to GAAP information can be found within this press release as well as in our periodic filings with the
We view Organic Revenue and Organic Revenue growth as important indicators when assessing and evaluating our performance on a consolidated basis and for each of our four segments, because it allows us to determine a comparable, but non-GAAP, measurement of revenue growth that is associated with the revenue sources that were a part of our business in both the current and prior year and that are expected to continue in the future. In addition, we believe Diluted Net Income Per Share - Adjusted provides a meaningful representation of our operating performance and improves the comparability of our results between periods by excluding the impact of the change in estimated acquisition earn-out payables, the impact of foreign currency translation and certain other non-recurring or infrequently occurring items. We also view EBITDAC and EBITDAC Margin as important indicators when assessing and evaluating our performance, as they present more comparable measurements of our operating margins in a meaningful and consistent manner. As disclosed in our most recent proxy statement, we use Organic Revenue, Diluted Net Income Per Share - Adjusted and EBITDAC Margin as key performance metrics for our short-term and long-term incentive compensation plans for executive officers and other key employees.
Beginning
Beginning
- “(Gain)/loss on disposal,” a caption on our consolidated statements of income which reflects net proceeds received as compared to net book value related to sales of books of business and other divestiture transactions, such as the disposal of a business through sale or closure.
- “Acquisition/Integration Costs,” which represent the acquisition and integration costs (e.g., costs associated with regulatory filings, legal/accounting services, due diligence and the costs of integrating our information technology systems) arising out of our acquisitions of
GRP (Jersey) Holdco Limited and its business,Orchid Underwriters Agency andCrossCover Insurance Services , andBdB Limited companies, which are not expected to occur on an ongoing basis in the future. - The period-over-period impact of foreign currency translation (“Foreign Currency Translation”), which is calculated by applying current-year foreign exchange rates to the various functional currencies in our business to our reporting currency of US dollars for the same period in the prior year.
We are presenting EBITDAC - Adjusted, EBITDAC Margin - Adjusted and Diluted Net Income Per Share - Adjusted for the current and prior year periods contained within this press release so these non-GAAP financial measures compare both periods on the same basis.
Non-GAAP Revenue Measures
- Total Revenues - Adjusted is our total revenues, excluding the period-over-period impact of Foreign Currency Translation.
- Organic Revenue is our core commissions and fees less: (i) the core commissions and fees earned for the first 12 months by newly acquired operations; (ii) divested business (core commissions and fees generated from offices, books of business or niches sold or terminated during the comparable period); and (iii) the period-over-period impact of Foreign Currency Translation. The term “core commissions and fees” excludes profit-sharing contingent commissions and therefore represents the revenues earned directly from specific insurance policies sold and specific fee-based services rendered. Organic Revenue can be expressed as a dollar amount or a percentage rate when describing Organic Revenue growth.
Non-GAAP Earnings Measures
- EBITDAC is defined as income before interest, income taxes, depreciation, amortization and the change in estimated acquisition earn-out payables.
- EBITDAC Margin is defined as EBITDAC divided by total revenues.
- EBITDAC - Adjusted is defined as EBITDAC, excluding (i) (gain)/loss on disposal, (ii) Acquisition/Integration Costs and (iii) the period-over-period impact of Foreign Currency Translation.
- EBITDAC Margin - Adjusted is defined as EBITDAC - Adjusted divided by Total Revenues - Adjusted.
- Diluted Net Income Per Share - Adjusted is defined as diluted net income per share, excluding the after-tax impact of (i) the change in estimated acquisition earn-out payables, (ii) (gain)/loss on disposal, (iii) Acquisition/Integration Costs and (iv) the period-over-period impact of Foreign Currency Translation.
Our industry peers may provide similar supplemental non-GAAP information with respect to one or more of these measures, although they may not use the same or comparable terminology and may not make identical adjustments and, therefore, comparability may be limited. This supplemental non-GAAP financial information should be considered in addition to, and not in lieu of, the Company's condensed consolidated financial statements.
For more information:
(386) 239-5770
Source:
FEDNAT HOLDING CO – 10-K – MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
New Public Health Study Findings Have Been Reported by Researchers at Ministry of Public Health (Effect of the Promulgation of the New Migrant’s Employment Law on Migrant Insurance Coverage in Thailand: An Interrupted Time Series Analysis, …): Health and Medicine – Public Health
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News